Proteomics seminar series for the South East
---Registration is free---
-- The London Proteomics Discussion Group --
Proteomics seminar series for the South East
Proteomics seminar series for the South East
We are a free, local proteomics seminar series in the South East,
with a focus towards networking, discussion and supporting early career researchers.
The LPDG...
was founded to bring together the large community of proteomics scientists all working in and around London. We aim to provide a space for discussion, with a focus on methods and early career researchers (two fundamental building blocks of good research!), on all topics related to proteomics. The meetings comprise of research talks framed by a proteomics methods challenge, lunch, refreshments and pizza - they are free to attend thanks to sponsorship.
Meeting Dates:
Happy to be here on Bluesky. We'll be doing a little series of "meet the committee members" over the next few weeks, having just held our elections for new members. Look out for the old and new faces coming soon 😊
— London Proteomics Discussion Group (@lpdg.bsky.social) December 8, 2024 at 7:00 PM
These seminars would not be possible without our amazing sponsors.
If you are interested in sponsoring an LPDG seminar,
please get in touch at sponsor@londonproteomics.co.uk
for 22nd May 2025 Time 12:00
Would you like to present at an LPDG meeting? Email: speaker@londonproteomics.co.uk
Research presentations from:
Dr Johanna Jackson is an Advanced Research Fellow at Imperial College London and an Alzheimer’s Society Dementia Leader. After her PhD at Imperial and post docs at Lund University and Imperial, she joined Eli Lilly where she became a team leader and co-chaired their Neuroplasticity Drug Discovery platform. She has led the UK DRI Multi-‘omics Atlas Project; an open resource mapping the cellular pathology of AD. Her lab investigates the vulnerability of synaptic components, repurposed therapeutics and biomarkers in order to therapeutically target the synapse in AD
Professor Kevin Mills is the Head of the Translational and Clinical Omics Group at University College London and is based at the Great Ormond Street Institute of Child Health. Our aim is to bring together state-of-the-art technology to find new drug targets, disease mechanisms, identify new biomarkers and develop new and more precise tests for the NHS. Our research group is composed of approximately 25 full time researchers and includes both clinical research fellows and basic scientists working side-by-side. We are unique in that we can use our omic capability to help understand disease mechanisms and identify drug targets, but also have the ability to translate any biomarker into a test to NHS or Industry accredited standards. We specialise in creating high throughput, multiplexed and bespoke panels of biomarkers for the diagnosis and monitoring of treatment of patients with complex diseases.
I am Principal Scientist in R&D Dpt in Lonza Biologics and focus on use of proteomics and multi-omics for applications in bioprocessing including MS-based analysis of host cell proteins, identification of predictive markers and targets for further improvements of expression system.
Dr Irbaz I. Badshah is a postdoctoral researcher specialising inbioinformatics and cell signalling. His recent work involves developing statistical methods to systematically identify biochemical networks in cancer cells, aiming to understand cancer dependencies and potential therapeutic targets. Currently, he is engineering efficient tools for the quantification and analysis of proteomic mass spectrometry data, utilising advanced computational approaches, including machine learning.
Xun is a Biomedial Research MRes Postgraduate student at Imperial College London. His research focuses to integrate proteomics, metabolomics, and lipidomics into a unified workflow using membrane-bound particles (including EV) enriched plasma from a single sample. Our results highlight a biphasic extraction protocol that enables robust recovery and detection of EV-associated analytes, advancing the development of a sensitive, minimal-invasive plasma biomarker platform.
March 2020 Meeting
Here is a list of answers to frequently asked questions for speakers, delegates and sponsors
The meetings are free to attend! We raise money through the generous support of sponsors for refreshments and venue hire. Sponsors are offered the opportunity to suggest a plenary research presentation or present a short (10min) sales talk.
Yes! Thanks again to the support of our sponsors, we are able to provide a sandwich buffet lunch, refreshments, and pizza and drinks to end. We try our best to get a range of refreshments to support diverse dietary requirements, but please let us know in advance if you have any specific needs.
We are always looking for new speakers - from PhD candidates to senior scientists within proteomics. We recruit speakers through personal invitations/networking, suggestions from deligates and from people contacting us directly. If you would like to present at a meeting, we would be delighted to hear from you, please get in touch at speaker@londonproteomics.co.uk
Registration is not essential, but it is very helpful for us to arrange catering and venues to ensure we don't over/under spend. In some cases, where space is limiting, registration may be essential and we will advertise this. If in doubt - register!
We do not have any funding to support delegates. However, if you are speaking, it may be possible to get a travel grant from the British Society for Proteome Research (BSPR). In some instances, we may be able to subsidise travel costs for speakers, but this is dependant on sponsorship for that meeting.
The organising committee is made up of early career (including PhD candidates) and more experienced scientist from academia and industry. We are very keen to have a bredth of backgrounds and experience on the committee, so if you would like to be involved, please get in touch by speaking to a committee member at a meeting, or emailing us - we would like to hear from you!
Our meetings are focused on proteomics and the delegates include proteomics-users from academia and industry. Therefore, at these meetings, there is a "captured audience" of possible clients. Sponsoring our meeting will allow you to present your product or service to a concentrated group of possible users. These meetings are only possible with sponsorship, and you will be contributing to the dissemination of science, and potentially meeting talented future employees through networking.
We have a range of options for meeting sponsorship. To sponsor a meeting, please get in touch at sponsor@londonproteomics.co.uk, we will be delighted to hear from you.
Yes! Just like our physical meetings, our webinars are completely free to attend.
Please register for our meeting in the normal way (click here). A link will be emailed to you prior to the meeting starting with instructions on how to join. Alternatively, a join link for the webinar will also be posted here immediately prior to it starting. For webinars run as a Microsoft Live Event, find instructions on how to join here, or using Zoom here.
The discussion will be mediated by the chairperson who will take questions from all attendees. The best way to contribute during the talk and to post questions is through our slack account.
The meetings are recorded and will be posted to our archive page.
The webinars are put on with the generous support academic institutions (as indicated in the webinar acknowledgements). We may accept sponsorship for webinars to allow us to run competitions and maintain our ability to put on free meetings in high quality venues. Webinar sponsors get the opportunity of a short presentation at the beginning of the webinar, and we may disseminate some information through our mailing list after the event. Sponsorship does not represent endorsement by LPDG or its affiliates.
If you still have unanswered questions after reading this page, wish to present a talk, suggest a venue or sponsor a meeting, please contact us.
The organising committee is made up of early and "not-so-early" career scientists
from academia and industry.
If you are interested in joining the committee, please get in touch.
Tom has been working for SCIEX since 2018, having worked at Phenomenex since leaving the University of Manchester in 2015. He currently helps SCIEXs customers across Nordic countries, UK and Ireland working in life science research and drug development. In particular he has an interest in accurate mass technologies.
I am Principal Scientist in R&D Dpt in Lonza Biologics and focus on use of proteomics and multi-omics for applications in bioprocessing including MS-based analysis of host cell proteins, identification of predictive markers and targets for further improvements of expression system.
Brett is a PhD student whose project focuses on skeletal muscle phosphoproteomics and membrane proteomics in response to α-melanocyte stimulating hormone infusion in healthy volunteers and patients with type 1 diabetes.
I am a final year PhD student in Prof. Ed Tate's group at Imperial College, with an interest in proteomics method development and profiling PTMs.
Jack is a post-doc in the Tate Group at Imperial with an interest in proteomics methodology development and bioinformatics.
Thomas is a PhD Student in the Vilar, Tate and Di Antonio groups at Imperial employing proteomics to interrogate DNA-protein interactions.
I am a lecturer in the Division of Systems Medicine at ICL. My research is multidisciplinary, using chemistry, bioinformatics and biology. For more info, click here.
I manage an MS lab at QMUL. I graduated from Drexel University (USA) in Biomedical Science, completing my PhD work at Harvard University. After a long stint in the private sector, I re-joined academia here in the UK researching lipidomics and proteomics.
Liz is Senior Lecturer in Molecular Spectroscopy at Imperial College London.
After my PhD in blood plasma cancer proteomics I moved to the Cancer Proteomics Group at UCL. I founded the LPDG as a focus group for the SE. I am currently at the Babraham Institute investigating protein degradation pathways using proteomics.
Vahitha is a lecturer in vascular pharmacology at WHRI, QMUL.
Georgina completed her PhD in the Jones lab at the University of Warwick and now works as a postdoc in the Thalassinos lab at UCL where she works on structural proteomics of proteins associated with Huntington’s disease.
I am a lecturer at QMUL investigating the role of biomolecular condensation in brain tumour development using biophysical proteomics.
Please email with any questions.
Particularly welcome are venue suggestions,
speaker suggestions or if you are thinking of sponsoring a meeting.
This seminar series is run by volunteers from academia and industry. We will try to reply to your email as quickly as possible, but please allow at least 5 days.
